Rinke Bos

2.3k total citations
15 papers, 737 citations indexed

About

Rinke Bos is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Rinke Bos has authored 15 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Rinke Bos's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (4 papers) and Platelet Disorders and Treatments (4 papers). Rinke Bos is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (4 papers) and Platelet Disorders and Treatments (4 papers). Rinke Bos collaborates with scholars based in Netherlands, United States and Australia. Rinke Bos's co-authors include Linda A. Sherman, Soon Boon Justin Wong, Rienk Offringa, Jocelyn Cheung, Kristi Marquardt, Suzanne van Duikeren, Pieter W. Kamphuisen, Rogier M. Bertina, Frits R. Rosendaal and Jeroen Eikenboom and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Rinke Bos

15 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rinke Bos Netherlands 8 541 434 158 64 61 15 737
María Vela Spain 12 295 0.5× 319 0.7× 118 0.7× 61 1.0× 57 0.9× 24 488
Jeannette Cany Netherlands 15 460 0.9× 376 0.9× 119 0.8× 39 0.6× 89 1.5× 20 632
Fumihiro Fujiki Japan 15 292 0.5× 281 0.6× 320 2.0× 42 0.7× 48 0.8× 42 580
Katrin U. Lundin Norway 11 475 0.9× 287 0.7× 94 0.6× 33 0.5× 71 1.2× 12 626
Hilde Omholt Norway 6 579 1.1× 384 0.9× 131 0.8× 37 0.6× 52 0.9× 7 689
K G Schepers United States 6 330 0.6× 421 1.0× 110 0.7× 56 0.9× 155 2.5× 7 624
Lynn Heltemes-Harris United States 15 395 0.7× 179 0.4× 202 1.3× 49 0.8× 123 2.0× 23 695
Annelies W. Turksma Netherlands 12 278 0.5× 240 0.6× 92 0.6× 42 0.7× 24 0.4× 20 443
Yu-Hsiang Chang Taiwan 8 461 0.9× 402 0.9× 127 0.8× 61 1.0× 92 1.5× 14 708
Hart S. Dengler United States 7 448 0.8× 101 0.2× 249 1.6× 53 0.8× 32 0.5× 7 666

Countries citing papers authored by Rinke Bos

Since Specialization
Citations

This map shows the geographic impact of Rinke Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rinke Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rinke Bos more than expected).

Fields of papers citing papers by Rinke Bos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rinke Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rinke Bos. The network helps show where Rinke Bos may publish in the future.

Co-authorship network of co-authors of Rinke Bos

This figure shows the co-authorship network connecting the top 25 collaborators of Rinke Bos. A scholar is included among the top collaborators of Rinke Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rinke Bos. Rinke Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Wang, Jing Jing, Marijn van der Neut Kolfschoten, Lucy Rutten, et al.. (2023). Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT. Blood. 143(4). 370–374. 6 indexed citations
3.
Wang, Jenny, Marijn van der Neut Kolfschoten, Lucy Rutten, et al.. (2023). OC 55.4 Recombinant Human anti-PF4 IgGs Regenerated from VITT Sera Activate Platelets and Endothelial Cells. Research and Practice in Thrombosis and Haemostasis. 7. 100494–100494. 1 indexed citations
4.
Kolfschoten, Marijn van der Neut, Clara Pérez‐Peinado, Daniëlle van Manen, et al.. (2023). Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine. Journal of Thrombosis and Haemostasis. 22(4). 1046–1055. 3 indexed citations
5.
Cecil, Denise L., Ekram Gad, Michael Gormley, et al.. (2022). Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer. Scientific Reports. 12(1). 13618–13618. 3 indexed citations
6.
Bos, Rinke, et al.. (2012). Immunologic Effects of an Orally Available BRAFV600E Inhibitor in BRAF Wild-type Murine Models. Journal of Immunotherapy. 35(6). 473–477. 6 indexed citations
7.
Bos, Rinke, Kristi Marquardt, Jocelyn Cheung, & Linda A. Sherman. (2012). Functional differences between low- and high-affinity CD8+T cells in the tumor environment. OncoImmunology. 1(8). 1239–1247. 62 indexed citations
8.
Bos, Rinke & Linda A. Sherman. (2010). CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes. Cancer Research. 70(21). 8368–8377. 336 indexed citations
9.
Wong, Soon Boon Justin, Rinke Bos, & Linda A. Sherman. (2008). Tumor-Specific CD4+ T Cells Render the Tumor Environment Permissive for Infiltration by Low-Avidity CD8+ T Cells. The Journal of Immunology. 180(5). 3122–3131. 111 indexed citations
10.
11.
Bos, Rinke, Suzanne van Duikeren, Hans Morreau, et al.. (2008). Balancing between Antitumor Efficacy and Autoimmune Pathology in T-Cell–Mediated Targeting of Carcinoembryonic Antigen. Cancer Research. 68(20). 8446–8455. 48 indexed citations
12.
Bos, Rinke, Suzanne van Duikeren, Thorbald van Hall, et al.. (2007). Characterization of Antigen-Specific Immune Responses Induced by Canarypox Virus Vaccines. The Journal of Immunology. 179(9). 6115–6122. 19 indexed citations
13.
Bos, Rinke, Suzanne van Duikeren, Thorbald van Hall, et al.. (2005). Expression of a Natural Tumor Antigen by Thymic Epithelial Cells Impairs the Tumor-Protective CD4+ T-Cell Repertoire. Cancer Research. 65(14). 6443–6449. 49 indexed citations
14.
Smakman, Niels, Liesbeth M. Veenendaal, Paul van Diest, et al.. (2005). Dual effect of KrasD12 knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy. Oncogene. 24(56). 8338–8342. 41 indexed citations
15.
Kamphuisen, Pieter W., Frits R. Rosendaal, Jeroen Eikenboom, Rinke Bos, & Rogier M. Bertina. (2000). Factor V Antigen Levels and Venous Thrombosis. Arteriosclerosis Thrombosis and Vascular Biology. 20(5). 1382–1386. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Vela Breakdown of academic impact, for papers by Jeannette Cany Breakdown of academic impact, for papers by Fumihiro Fujiki Breakdown of academic impact, for papers by Katrin U. Lundin Breakdown of academic impact, for papers by Hilde Omholt Breakdown of academic impact, for papers by K G Schepers Breakdown of academic impact, for papers by Lynn Heltemes-Harris Breakdown of academic impact, for papers by Annelies W. Turksma Breakdown of academic impact, for papers by Yu-Hsiang Chang Breakdown of academic impact, for papers by Hart S. Dengler
Rankless by CCL
2026